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Abstract
Background: The understanding of the cellular responses implicated in perinatal brain damages and the 
characterization of the various mechanisms involved might open new horizons for understanding the time of onset of 
a brain hypoxic-ischemic lesion and for effective therapeutic strategies.
Methods: We performed an immunohistochemical investigation on brain and brainstem sections of 47 peripartum 
deaths. The gradation and localization of the expression of antibodies such as TNFα, IL-1β, IL-6, HSPs, β APP, anti-TrypH, 
GAP43, GFAP, COX2, ORP-150, could be correlated with an hypoxic-ischemic damage to document a significant 
correlation between response and the time of onset acute (≤8 hs) or non-acute (≥8 hs ≤48 hs).
Results and Discussions: In non-acute cases HSP70 reaction was prominent in the neuron cytoplasm, while in acute 
cases a mild reaction was evident in sporadic fields. HSP90 exhibited a similar pattern of positivity as HSP70. In acute 
group, ORP150 expressed an intense reaction showing a granular pattern in the cytoplasm of the neurons in the cortex 
of the infarcted areas. In non-acute group the positive reaction was more intense in astrocytes and less extended in 
neurons. COX2 reaction exhibited the strongest positive reaction in the neuronal cell bodies of acute cases, while a 
immunolabeling was prominent in the glial cytoplasm in the non-acute cases.
Conclusions: Chaperones HSP70 and 90, ORP-150 reaction, and COX2 protein, have provided very interesting results. 
These results would suggest to the clinicians to extend the differential diagnosis of a too large perinatal hypoxic-
ischemic insult category to delineate a more accurate chronological judgement.
Introduction
The timing of perinatal hypoxia is complex and incom-
pletely understood. It is traditionally based on clinical,
laboratory and instrumental criteria which are nonspe-
cific markers of a difficult birth [1,2]. These non-specific
intra-partum markers provide poor information on the
timing and duration of an asphyxiating insult [3].
Autopsy, placental and cord examination, laboratory tests
and genetic studies may explain both the cause of death
and the time of onset of the neuropathology. Brain histo-
logical examination can provide useful information on
the timing of an hypoxic - ischemic lesion; the patterns of
perinatal brain injury depend on the aetiology and the
stage of development of the foetal nervous system, since
the vulnerabilities of gray and white matter differ depend-
ing on post-conceptional age and on neuro-anatomic site
[4,5]. New insights into the mechanisms involved in neo-
natal hypoxic-ischemic brain injury have recently trans-
formed the old concept that most cases are the results of
an acute hypoxia during labour and delivery. Current
knowledge on the chronology of the response of cerebral
tissue following the occurrence of a hypoxic insult
emphasizes immunohistochemical investigations on
brain specimens as useful tools in perinatal-related death
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autopsy. Understanding the time of onset of the brain
lesion is of paramount importance to medical and legal
professionals. In Courts, in fact, much of the debate
focuses on whether or not there is evidence of acute
intrapartum hypoxia and if so, whether the care provided
was timely and adequate [6,7].
In the present study we performed an immunohis-
tochemical investigation to detect brain markers
expressed during the perinatal hypoxic-ischemic event
and to determine if and to which extent, the gradation of
the expression of markers such as Tumour Necrosis Fac-
tor-alfa (TNFα), Interleukins (IL-1β, IL-6), macrophage
marker (CD68), Heat Shock Proteins (HSPs), β Amyloid
Precursor Protein (β APP), anti-Ttryptophan Hydroxylase
(anti-TrypH), Growth Associated Protein43 (GAP43),
Glial Fibrillar Acidic Protein (GFAP), Cyclooxygenase2
(COX2), Oxygen-Regulated Protein150 (ORP-150), could
be correlated with an hypoxic-ischemic damage to docu-
ment a significant correlation between response and time
of onset (acute or non-acute).
Materials and methods
We proceeded to review the autopsies performed on
newborns who had died following a difficult birth at the
Departments of Forensic Pathology of the University of
Foggia and at the University of Genoa during the period
1999-2008, for a total of 47 peripartum deaths.
Peripartum cases were represented by newborns with a
gestational age between 40 and 42 weeks dying within 48
hours after birth. Post-mortem examination was per-
formed within 24 hours from death. We excluded all
cases in which congenital anomalies and/or central ner-
vous system or cardiac malformations, infections, chro-
mosomal or metabolic abnormalities were diagnosed.
On the basis of clinical data (pregnancy, labour, fetal
cardiotocography (CTG) tracing and Apgar score) the
cases were so divided:
▪ Cases in which the hypoxic insult has acted in a non-
acute manner (≥8 hs ≤48 hs) during the late period of 
pregnancy: n = 23 (non-acute group);
▪ Cases in which the hypoxic-ischemic insult has 
occurred in an acute (≤8 hs) and sudden way during 
the labour: n = 24 (acute group);
▪ Perinatal death (trauma and infanticides) with 
immediate neonatal death due to brain traumatic 
injuries: n = 15 (control group).
Significant macroscopic findings were searched for dis-
tinctive patterns of damage, specifically in the deep gray
and underlying white matters of the midbrain, lateral
geniculate bodies, posterior putamen and peri-rolandic
cortex. We looked for principal types of acute haemor-
rhagic and hypoxic-ischaemic brain damage in the neo-
nate such as
▪ Haemorrhagic lesions (germinal matrix and intra-
ventricular haemorrhage, choroid plexus haemor-
rhage, cerebellar haemorrhage, subpial haemorrhage);
▪ White matter destructive lesions such as periven-
tricular leukomalacia, subcortical leukomalacia (with 
or without infarction of overlying cerebral cortex), 
telencephalic leukomalacia (selective loss of myelina-
tion glia);
▪ Grey matter destructive lesions such as pontosubic-
ular necrosis, acute degeneration of other neuronal 
groups and infarction especially in the cerebral cor-
tex, basal ganglia, thalamus, brain stem [5].
Standard sample blocks were taken from the cerebral
cortex, white and grey matters, basal ganglia, thalami and
the brainstem. All tissue samples were fixed in 10% form-
alin for 48 hours and then processed and embedded in
paraffin. For each case, total sections of about 4 μm thick-
ness were cut and stained with haematoxylin and eosin
(H&E), Golgi, Perls, and Von Kossa methods.
An immunohistochemical study was performed on tis-
sue sections using a panel of antibodies chosen on the
basis of the most recent scientific literature on the matter
of brain hypoxic-ischemic damage: GFAP, TNFα, IL-1β,
IL-6, CD68 (MAC387 clone), HSP27, 70 and 90, COX2,
ORP150, β-APP, TrypH, GAP-43, apoptosis (TUNEL).
The sections in paraffin were rehydrated and incubated
for 20 min in methanol containing 10% of H2O2 to block
endogenous peroxidase. The sections were pretreated to
facilitate antigen retrieval and to increase membrane per-
meability to antibodies and were then incubated with the
primary antibody (see Table 1). The detection system uti-
lized was the LSAB+ kit (Dako, Copenhagen, Denmark),
a refined avidin-biotin technique in which a biotinylated
secondary antibody reacts with several peroxidase-conju-
gated streptavidin molecules. The positive reaction was
visualized by 3,3-diaminobenzidine (DAB) peroxidation
according to standard methods. The sections were coun-
terstained with Mayer's haematoxylin, dehydrated, cover-
slipped, and observed in a Leica DM4000B optical
microscope (Leica, Germany) connected to a computer-
ized system with a photo camera (DC 480 Leica, Ger-
many). The samples were also examined under a confocal
laser scanning microscope and a three-dimensional
reconstruction was performed (True Confocal Scanner
TCS SPE, Leica, Germany). A preliminary semi-quantita-
tive evaluation of the immunohistochemical findings was
made by two different investigators without prior knowl-
edge.
The reactions were graded as follows: 1. (0): not
expressed; 2. (+): isolated and disseminated expression; 3.
(++): expression in groups or widespread foci; 4. (+++):
widespread expression.Riezzo et al. Diagnostic Pathology 2010, 5:49
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Statistical Analysis
Semi-quantitative evaluation of the immunohistochemi-
cal findings and gradation of the immunohistochemical
reaction were described with an ordinal scale and the
median value reported. Analysis of variance for the non
parametric data between groups was performed using
Kruskal-Wallis test. When differences were found to be
significant, analysis between the unmatched groups were
performed with a Dunn's Multiple Comparison post hoc
test. Significance level was set to 5% (SPSS ver. 16.01 for
Windows - SPSS Inc., Chicago USA)
Results
The pathological findings are summarized in Figure 1. In
the acute group necrosis of the basal ganglia (8 cases) and
of the thalamus (6 cases) were observed; intraventricular
haemorrhages (4 cases), necrosis of tegmentum (3 cases)
and two cases of infarction of the cerebral cortex were
described. Three cases of necrosis of the basal ganglia, 12
cases of subcortical leukomalacia with infarction of the
cerebral cortex and 8 cases without infarction were
observed in the non-acute group. In acute insult the
microscopic study of the brain samples, typically showed
massive brain oedema (Figure 2), bleeding into the chor-
oid plexus with massive intra-ventricular haemorrhages,
sub-pial haemorrhages involving the cerebrum or cere-
bellum. Neuronal apoptosis and necrosis were observed.
Frank infarction affected the cerebral cortex and white
matter, in which glial cells had vesicular nuclei and fine
fibrillary cytoplasmic processes. Necrosis was observed
Table 1: Panel of antibodies selected in the study
Antibody against Pre--treatment Incubation time of primary 
antibody, temperature
Concentration of 
primary antibody
GFAP (Dako, Copenhagen, Denmark) No pre-treatment 120 min, 20°C 1:300
TNFα (Santa Cruz, CA, USA) boiling in 0.1 M Citric Acid buffer. 120 min, 20°C 1:600
IL-1β (Santa Cruz, CA, USA) boiling in 0.25 mM EDTA buffer. 120 min, 20°C 1:4000
IL-6 (Santa Cruz, CA, USA) 5 min Proteolytic Enzyme (Dako, 
Copenhagen, Denmark), 20°C.
120 min, 20°C 1:2000
CD68 (Serotec, United Kingdom) 5 min Proteolytic Enzyme (Dako, 
Copenhagen, Denmark), 20°C.
120 min, 20°C 1:200
HSP 27 (NovaCastra, United Kingdom) boiling in 0.25 mM EDTA buffer.. 120 min, 20°C 1:20
HSP 70 (NovaCastra, United Kingdom) boiling in 0.25 mM EDTA buffer.. Overnight, 20°C 1:100
HSP 90 (NovaCastra, United Kingdom) boiling in 0.25 mM EDTA buffer.. 120 min, 20°C 1:50
COX2 (Santa Cruz, CA, USA) 5 min Proteolytic Enzyme (Dako, 
Copenhagen, Denmark), 20°C.
120 min, 20°C 1:100
ORP-150 (IBL, Gunma, Japan) boiling in 0.1 M Citric Acid buffer. 120 min, 20°C 1:200
β-APP (NovaCastra, United Kingdom) boiling in 0.1 M Citric Acid buffer. Overnight, 20°C 1:300
TrypH (NovaCastra, United Kingdom) boiling in 0.1 M Citric Acid buffer. Overnight, 20°C 1:50
GAP-43 (Santa Cruz, CA, USA) boiling in 0.1 M Citric Acid buffer 120 min, 20°C 1:2000
TdT enzyme (Chemicon, CA, USA) 15 min in Proteinase K (20 μg/ml), 20°C 60 min, 38°C 30 μl of TdT in 70 μl of 
reaction buffer 
(Chemicon, CA, USA)Riezzo et al. Diagnostic Pathology 2010, 5:49
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in the basal ganglia, thalamus, internal granular layer of
the cerebellar cortex, inferior colliculi, inferior olivary
nucleus and brainstem tegmentum.
Particularly significant was the immunohistochemical
study of the brain and brainstem sections. In non-acute
cases HSP70 reaction was prominent in the neuron cyto-
plasm of the affected regions, while in acute cases a mild
reaction was evident in sporadic fields (Figure 3). HSP90
exhibited a similar pattern of positivity as HSP70 (Figure
4). In the acute group, ORP150 expressed an intense reac-
tion showing a granular pattern in the cytoplasm of the
neurons in the cortex of the infarcted areas. Differently,
in the non-acute group the positive reaction was more
intense in astrocytes and less extended in neurons (Figure
5). COX2 reaction exhibited a strong positive reaction in
the neuronal cell bodies while immunolabeling was
prominent in the glial cytoplasm in the non-acute cases
(Figure 6).
The reaction with GFAP has shown a constant and
strong positivity in astrocytes, which was documented
also in control cases, without significant differences in
the different groups, therefore not allowing to distinguish
them. However, the reaction represents an excellent mor-
phological definition of astrocytes, therefore permitting
to recognise the different kinds of astrocytes which
express GFAP in different ways, so as to better identify
the cells where the positive reaction is a consequence of a
hypoxic-ischemic insult.
The reaction to β-APP has shown a strong positivity
not only in the axons but also in the neuronal body and in
the glia in control cases. In the non-acute cases the inten-
sity of neuronal and glial expression has shown an almost
constant and widespread positivity, therefore confirming
data reported in literature showing a positive expression
of the protein already during acute stages (<3 hours) [8].
TrypH and GAP-43 did not present significant results.
Reaction to TrypH was weakly positive mainly in neurons
especially in some cases belonging to the acute group,
while the reaction to GAP-43 showed positivity limited
exclusively to glial cells in a few non-acute cases and only
vascular in some acute cases.
Figure 1 Pathological findings in acute and non-acute groups.Riezzo et al. Diagnostic Pathology 2010, 5:49
http://www.diagnosticpathology.org/content/5/1/49
Page 5 of 12
Regarding cytokines (IL-1β, IL-6, TNFα), we observed a
mild and sporadic positive reaction in neurons only in
some non-acute cases (25%), associated to vascular and
glial positivity. The expression in acute cases was shown
only at vascular level. In particular, the reaction to IL-1 β,
although weak, was positive mainly in neurons since the
acute stages and in neurons but also in glial cells in the
following stage (non-acute).
CD68, marker of microglia, did not present conclusive
results, since sporadic and scattered tissue positivity was
detected in the acute group, even if not in all cases, with
the exception of newborns belonging to the non-acute
group in which the expression was positive in all cases.
Regarding apoptosis, we know that the damage caused
by hemorrhagic lesions is primarily destructive with sec-
ondary ischemic alterations. For example, in germinal
matrix cells, in presence of hemorrhagic lesions, apopto-
sis must be interpreted as a secondary phenomenon.
Also, there is scientific evidence that ponto-subicular
necrosis in cases of perinatal hypoxic-ischemic brain
damage is partly to be related to cellular oxidative stress
with typical apoptotic alterations with DNA cleavage [9].
The results about the tested antibodies, the semi-quan-
titative evaluation and statistical analysis are summarized
in Table 2 and Table 3.
Discussion
The immunohistochemical picture obtained using the
panel of the antibodies, has shown the existence of a
rather precise chronology of expression of the different
markers of hypoxic-ischemic brain damage in newborns,
which is correlated to the duration of the same insult and
is to be ascribed, essentially, to a different stimulation of
the different cellular types and also to a different response
by the same cells to the ischemic insult. Some immuno-
histochemical markers have been shown to be more reli-
Figure 2 (A) CTG tracing. Sudden decelerations (arrow) that do not recover: urgent delivery ("rescue") is indicated. This tracing permits the diagnosis 
that the fetus (40ws.) suffered an acute, rather profound, ischemic event just prior to delivery due to the mother's prolonged cardiac arrest. (B-C) Same 
case as in (A): CT (midventricular level) appearance with enlarged lateral ventricles and generalized brain swelling at autopsy. (D) Histology of the cor-
tical layer shows it to be oedematous with nuclear pyknosis.Riezzo et al. Diagnostic Pathology 2010, 5:49
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Figure 3 (A) In non-acute cases (~10 hs) HSP70 reaction was prominent in the neuron cytoplasm of the affected regions. (B) (insert) Confocal 
laser scanning microscope: typical morphological features of neuronal (green) apoptosis associated with marked condensation of chromatin and its 
fragmentation into discrete bodies. (C-D) In acute cases a mild HSP70 reaction was evident in sporadic fields.
Figure 4 Immunohistochemical staining for HSP90 at 12 hs (A-B) and at 15 hs (C) exhibited an intense reaction in the cytoplasm of the neu-
rons. The reaction must be compared with acute case (≤8 hs) (D) in which a mildly granular reaction is evident in the neurons.Riezzo et al. Diagnostic Pathology 2010, 5:49
http://www.diagnosticpathology.org/content/5/1/49
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able than others in the evaluation of the timing of the
neonatal hypoxic-ischemic damage. In particular, chaper-
onins HSPs have provided very interesting results [10].
Recently, has been demonstrated that brain ischemia
depletes ATP and changes intracellular homeostasis, thus
disabling ATP-dependent protein quality control systems
including molecular chaperones, folding enzymes, and
protein degradation components during and after isch-
emia [10]. In our study HSP70, which is not expressed in
control cases, has shown a mild positivity in both neu-
ronal and glial scattered foci beside a weak intravascular
positivity, since the acute stages of the hypoxic insult. In
the non-acute group, a greater neuronal and glial involve-
ment and intravascular positivity of HSP70 expression
has been observed. The reaction was more intense in the
cytoplasm of the neurons and included infrequent HSP70
protein positive inclusions in glial cells of the non-acute
group [11]. HSP90, characterised by later expression,
showed its highest expression in non-acute cases at neu-
ronal, glial and intravascular level, compared with the
acute group.
Data emerging from the reaction with ORP150 are in
agreement with those reported in literature [12], showing
a constant neuronal and glial positivity, in scattered but
widespread foci, in most cases belonging to the non-acute
group and being completely negative in the glial cells of
the acute group. ORP150 was acutely expressed in neu-
rons, strongly suggesting that strongly expression of
ORP150 may confer neuronal resistance to early ischemic
injury [12]. Therefore, this antigen-antibody reaction can
provide useful indications about the time of onset of the
hypoxic-ischemic damage.
COX2, the protein responsible of prostaglandin synthe-
sis [13], expressed by vascular endothelium in control
cases, appeared more positive not only at vascular level
b u t  a l s o  i n  g l i a l  c e l l s  i n  n o n - a c u t e  c a s e s .  I n  c o n t r a s t ,
COX2 was strongly expressed in neurons in the acute
group. This finding will need further development
Figure 5 ORP150 immunohistochemical expression related to cell viability: (A-B) in non-acute case we detected mildly neuron reaction 
and positive astrocytes stain. (C) Strong neuron reaction to ORP150 in acute case. (D) Confocal laser scanning microscope: cortical layers showed 
intense and diffuse reactions granular pattern in the cytoplasm of the neurons (ORP150 reaction is in orange).Riezzo et al. Diagnostic Pathology 2010, 5:49
http://www.diagnosticpathology.org/content/5/1/49
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because it contrasts with data reported in literature in
which is described a greater expression in the acute cases
of asphyxia in the absence of a precise time reference
[14].
Our results demonstrated that molecular chaperones
HSP70 and HSP90 are strongly expressed in neurons as
later reaction [15]. We have demonstrated that ORP150
expression is correlated with cell survival indicating that
induction of this stress protein may confer neuronal resis-
tance to acute ischemic injury [12]. COX2 is a precious
marker to detect acute neuronal damage during the early
stage of focal ischemic encephalopathy [13].
The international scientific panorama is actually rich of
studies aiming to the research of histological, histochemi-
cal and immunohistochemical markers which can pro-
vide more and more accurate information about the time
of onset of hypoxic-ischemic brain damage. However,
data reported by literature appear fragmentary and con-
tradictory, often concerning experimental studies per-
formed only on animals. Moreover it should be
underlined that most reports concern experimental stud-
ies which have used markers with late expression (>24
hours) which, therefore, are scarcely reliable in cases of
perinatal hypoxic-ischemic brain damage due to intra-
partum asphyxia. These neurobiological insights into the
mechanisms of the cellular responses implicated in perin-
atal brain damages, and the characterization of the vari-
ous mechanisms involved might open new horizons for
understanding the time of onset of a brain hypoxic-isch-
emic lesion and for effective therapeutic strategies [16]. It
is well known that the ability of current technologies,
such as electronic foetal monitoring, to identify intrapar-
tum hypoxia-ischemia is limited [17]. Neuroradiological
techniques to identify injury in the newborns cannot
resolve the timing of the injury to within several hours
without considerable input from the clinical history
(abruption, prolapse, rupture, etc.) or the CTG tracing,
but they can apparently exclude an ante-partum process.
Figure 6 Confocal laser scanning microscope: COX2 positivity at (A) vascular level demonstrated in (C) too. (B) COX2 immunolabeling was 
prominent in the glial cytoplasm in the non-acute cases while (D) COX2 reaction exhibited a strong positive reaction in the neuronal cell bodies in 
the acute cases.Riezzo et al. Diagnostic Pathology 2010, 5:49
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Table 2: Results of immunohistochemical markers response in glial cells
Acute (A) (≤8 hs) 
Median Expression
Non-acute (NA) (≥8 
hs ≤48 hs) Median 
Expression
Controls (C) Median 
Expression
Significant Significance Level Levels
GFAP +++ +++ +++ A vs C ns
NA vs C ns
A vs NA ns
TNF-α - + - A vs C ***
NA vs C ns
A vs NA ***
IL-1β - + - A vs C ***
NA vs C ns
A vs NA ***
IL-6 - ++ - A vs C ***
NA vs C ns
A vs NA ***
MAC387 ++ + - A vs C ***
NA vs C ***
A vs NA **
HSP 27 --- A  v s  C n s
NA vs C ns
A vs NA ns
HSP 70 + ++ - A vs C ***
NA vs C ***
A vs NA ***
HSP 90 + ++ - A vs C ***
NA vs C ***
A vs NA ***
COX2 ++ - A vs C ***
NA vs C ns
A vs NA ***
ORP-150 - ++ - A vs C ***
NA vs C ns
A vs NA ***
β-APP + ++ ++ A vs C ***
NA vs C ***
A vs NA nsRiezzo et al. Diagnostic Pathology 2010, 5:49
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TrypH --- A  v s  C n s
NA vs C ns
A vs NA ns
GAP-43 - + - A vs C ***
NA vs C ns
A vs NA ***
Apoptos
is 
(TUNEL)
+ ++ - A vs C ***
NA vs C ***
A vs NA ***
The reactions were graded as follows: 1. (0): not expressed, 2. (+): isolated and disseminated expression, 3. (++): expression in groups or 
widespread foci, 4. (+++): widespread expression.
NS = p > 0.05, * = p < 0.05, ** = p < 0.01, *** = p < 0.001
Table 2: Results of immunohistochemical markers response in glial cells (Continued)
Table 3: Results of immunohistochemical markers response in neurons
Acute (A) (≤8 hs) 
Median 
Expression
Non-acute (NA) 
(≥8 hs ≤48 hs) 
Median 
Expression
Controls (C) 
Median 
Expression
Significance Level
GFAP -- A  v s  C n s
NA vs C ns
A vs NA ns
TNF-α - + - A vs C ***
NA vs C ns
A vs NA ***
IL-1β + ++ - A vs C ***
NA vs C ***
A vs NA ***
IL-6 - + - A vs C ***
NA vs C ns
A vs NA ***
MAC387 --- A  v s  C n s
NA vs C ns
A vs NA ns
HSP 27 --- A  v s  C n s
NA vs C ns
A vs NA nsRiezzo et al. Diagnostic Pathology 2010, 5:49
http://www.diagnosticpathology.org/content/5/1/49
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In cases of neonatal death it is essential the contribution
of post-mortem examination complemented by toxico-
logical, microbiological and genetic investigations [18].
The histological study of the brain with traditional his-
tochemical techniques can provide relevant data since it
is well known that depending on mechanism, severity and
timing of the insult, the distribution and the histological
pattern of lesions in the brain changes dramatically [5,19].
By means of immunohistochemical techniques applied in
studies both on animals and humans, it has been possible
to identify in the brain tissue some markers of hypoxic-
ischemic damage with reliable and reproducible results
[20-23].
In particular, chaperonins HSP70 and HSP90, ORP150
reaction, and COX2 protein, have provided very interest-
ing results. Finally, these results would suggest a message
to the clinicians to extend the differential diagnosis of a
too large neonatal hypoxic-ischemic insult chronological
category to delineate a more accurate judgement [16].
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